title: Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals.
abstract: BACKGROUND
  Antimicrobial stewardship programs are advised to measure and risk-adjust antimicrobial use to facilitate interhospital comparisons, a process called benchmarking. The purpose of this investigation was to evaluate a new benchmarking strategy for antibacterials.
  
  
  METHODS
  Hospital-wide adult antibacterial drug use in 2009 was measured as days of therapy (DOT) and length of therapy (LOT) from billing records in 70 US academic medical centers (AMCs). Patients were assigned to 1 of 35 clinical service lines (CSL) based on their Medicare Severity Diagnosis Related Group. Expected (E) use was determined by indirect standardization and compared with observed (O) use.
  
  
  RESULTS
  Of 1,791 ,180 discharged adults, 63.7% received antibacterial drugs; the range by CSL was 14.3% (psychiatry) to 99.7% (lung transplant). Mean ± SD hospital-wide use was 839 ± 106 DOTs (range, 594-1109) and 536 ± 53.0 LOT (range, 427-684) per 1000 patient-days. The ventilator support CSL had the most DOT per discharge, 39.4 ± 9.4 days; the LOT was 21.5 ± 4.5 days. The hospital-wide O/E ratio range was 0.7-1.45; in 5 AMCs the ratio exceeded the 90% confidence interval (CI) and was below the 90% CI in 6. Variability in use was explained by the proportion of treated patients within each CSL and mean LOT and DOT per discharge.
  
  
  CONCLUSIONS
  Adult antibacterial drug use was benchmarked to expected use adjusted for patient mix, and outlier hospitals were identified. Differences between expected and observed use reflect usage patterns that were benchmarked and are targets for evaluation and intervention.
authors: Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, USA. rpolk@vcu.edu
authors: Ron E
authors: RE
authors: Polk
authors: Samuel F
authors: SF
authors: Hohmann
authors: Sofia
authors: S
authors: Medvedev
authors: Omar
authors: O
authors: Ibrahim
mesh_terms: D000046:Academic Medical Centers; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019985:Benchmarking; D004363:Drug Utilization / Q000592:standards* / Q000706:statistics & numerical data*; D006761:Hospitals; D006801:Humans; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents